Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2009
11/26/2009US20090291050 Particulate materials
11/26/2009US20090291049 Targeted delivery to human diseases and disorders
11/26/2009DE102008001788A1 Verwendung organomodifizierter Siloxanblockcopolymere zur Herstellung kosmetischer oder pharmazeutischer Zusammensetzungen Using organo siloxane block copolymers for the preparation of cosmetic or pharmaceutical compositions
11/26/2009CA2724976A1 Novel ghrelin analogues
11/26/2009CA2724821A1 Polymer derivative of docetaxel, method of preparing the same and uses thereof
11/26/2009CA2724818A1 New optically pure compounds for improved therapeutic efficiency
11/26/2009CA2724782A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009CA2723954A1 Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer
11/26/2009CA2698582A1 Peptide having an extending action for half-life of object peptide in plasma
11/25/2009EP2123667A1 Brain-migrating polypeptide having polyvalent bond and improved metabolic stability
11/25/2009EP2123328A1 Galanthamine derivatives, methods for their obtaining and use
11/25/2009EP2123305A1 Linear self-eliminating oligomers
11/25/2009EP2123304A1 Compounds suited as nanocarriers for active agents and their use
11/25/2009EP2123296A1 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same
11/25/2009EP2123295A1 Therapeutic agent for interstitial pneumonia
11/25/2009EP2123288A1 C<sb>70</sb>-containing liposome, method for producing the same, and use of the same
11/25/2009EP2123284A1 Prophylactic and/or therapeutic agent for cardiac infarction
11/25/2009EP2123278A1 Eye drop reparation comprising latanoprost
11/25/2009EP2123275A1 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
11/25/2009EP2123274A1 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
11/25/2009EP2123270A1 Iron metabolism-improving agent
11/25/2009EP2123269A1 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion
11/25/2009EP2123259A1 Liposome preparation for iontophoresis having antioxidant component encapsulated therein
11/25/2009EP2123257A2 Stable high Vitamin C content polyol-in-oil emulsified system and its preparation
11/25/2009EP2121754A1 Pegylated a fab
11/25/2009EP2121742A2 Metastasis-specific peptides and their diagnostic and therapeutic applications
11/25/2009EP2121725A1 C-terminal attachment of two chemical groups to peptides
11/25/2009EP2121716A1 Compositions of stable tiacumicins
11/25/2009EP2121139A1 Formulations for cancer treatment
11/25/2009EP2121057A1 Polymerization with precipitation of proteins for elution in physiological solution
11/25/2009EP2121033A2 Color-marked oligosaccharides or polysaccharides
11/25/2009EP2121030A2 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
11/25/2009EP2121029A2 Prodrugs and methods of making and using the same
11/25/2009EP2121027A2 Cyclodextrin formulations
11/25/2009EP2121025A2 Methods and compositions for the delivery of a therapeutic agent
11/25/2009EP2121024A2 Stabilization of vitamin b12
11/25/2009EP2121023A1 Controlled release composition and process
11/25/2009EP2120990A1 Reducing post-operative adhesion formation with intraperitoneal glutamine
11/25/2009EP2120974A1 Self-assembling amphiphilic polymers as antiviral agents
11/25/2009EP2120966A2 Polymeric short interfering rna conjugates
11/25/2009EP2120914A1 Use of gentian violet in treatment of atopic dermatitis
11/25/2009EP2120913A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/25/2009EP2120908A1 Solvating system and sealant for medical use
11/25/2009EP2120887A1 Controlled-release preparation containing cilostazol and process for the preparation thereof
11/25/2009EP2120876A2 Nanoparticle delivery systems for membrane-integrating peptides
11/25/2009EP2120873A1 Topical dosage form comprising tri-substituted glycerol compounds
11/25/2009EP2120872A1 Nanoemulsion
11/25/2009EP2120871A1 Linker-based lecithin microemulsion delivery vehicles
11/25/2009EP2120870A2 Terbinafine formulation for iontophoresis
11/25/2009EP2120868A2 Low-dose mometasone formulations
11/25/2009EP2120865A2 Method of producing a composition from an oleogel and an aqueous gel and the composition
11/25/2009EP2120863A1 Pharmaceutical compositions based on a microemulsion
11/25/2009EP2120862A1 Use of a surfactant for the preparation of a formulation for the treatment of adipose dieseases
11/25/2009EP2120722A1 Method of controlling a release of a material carried by ultrasound sensitive particles
11/25/2009EP2120585A1 Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
11/25/2009EP2120561A1 Compositions for treating biofilms and methods for using same
11/25/2009EP1773914B1 Polyamino acids functionalised by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications
11/25/2009EP1322299B1 Composition for the transdermal delivery of fentanyl
11/25/2009EP1096962B1 Method of obscuring immune recognition
11/25/2009CN101589145A Modified soluble FGF receptor Fc fusions with improved biological activity
11/25/2009CN101588820A Alpha-lactalbumin composition
11/25/2009CN101588819A Factor IX moiety-polymer conjugates having a releaseable linkage
11/25/2009CN101588818A Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family
11/25/2009CN101588802A Skin adhesive preparation comprising stabilized donepezil
11/25/2009CN101588794A Modified release pharmaceutical composition and a process of making the same
11/25/2009CN101588792A Nanoemulsion
11/25/2009CN101588791A Diclofenac gel
11/25/2009CN101588790A Superporous hydrogels
11/25/2009CN101588770A Intraocular drug delivery systems
11/25/2009CN101586256A Preparation of porosity electrospun fiber
11/25/2009CN101586142A Research approach for element for forcing knubble microenvironment and application thereof
11/25/2009CN101586137A Method for adding ethanol to enhance beta-cyclodextrin yield
11/25/2009CN101585920A Method for preparing poly(pseudo)rotaxanes with gamma-cyclodextrin and polyvinyl alcohol
11/25/2009CN101585888A glucosan aliphatic acid graft manufacturing method and use
11/25/2009CN101585882A Fusion protein for treating breast cancer and application thereof
11/25/2009CN101584889A External in-situ forming matrix used for treating periodontal diseases
11/25/2009CN101584867A Methods and compositions for enhanced delivery of bioactive molecules
11/25/2009CN101584866A Polyethylene glycol modified human interleukin-2, preparation method and application thereof
11/25/2009CN101584865A Corn core carrier modifying method
11/25/2009CN101584864A Method for producing water soluble moistureproof film coating premixing agent
11/25/2009CN101584859A Orally-taken hirudin microsphere preparation and preparation method thereof
11/25/2009CN101584858A Stable protein formulations
11/25/2009CN101584857A Ophthalmic preparation and preparation method thereof
11/25/2009CN101584855A Pharmaceutical preparation and preparation method thereof
11/25/2009CN101584854A Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same
11/25/2009CN101584831A Medicinal composition for treating gynecological diseases and vaginal jelly thereof
11/25/2009CN101584764A Medicinal dripping pill for treating chronic cystitis
11/25/2009CN101584758A Medicine composition for treating kidney deficiency
11/25/2009CN101584750A Compound fig preparation
11/25/2009CN101584735A Pharmaceutical composition for preventing and treating chicken bursal disease and nephrotic bronchitis and preparation method thereof
11/25/2009CN101584723A Medicine for treating psoriasis and preparation method thereof
11/25/2009CN101584715A Spray for preventing and treating skin damnification and resisting infection
11/25/2009CN101584711A Nano-silver antibacterial washing fluid
11/25/2009CN101584683A Metolazone slow-release capsule and method for preparing same
11/25/2009CN101584682A Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof
11/25/2009CN101584679A Novel oral capsule preparation for treating cancer and AIDS
11/25/2009CN101584678A Sertaconazole antibacterial effervescing agent, preparation method and application thereof
11/25/2009CN101584677A Trimebutine maleate sustained-release tablet
11/25/2009CN101584676A Matrine sustained release preparation and preparing method thereof
11/25/2009CN101584675A Slow-release avermectin tablet for livestock and poultry and preparing method thereof
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 1712